GlassScriptPhysician profile
Gerard Mosiello
NPI 1982687836
$14,086.27
in general payments reported to CMS, 2019-2025
13 companies · $3,995 in 2025
The $3,995 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $419 · 2021: $865 · 2022: $1,367 · 2023: $1,487 · 2024: $4,553 · 2025: $3,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,256 · Food and Beverage: $4,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,256.25 |
| Food and Beverage | $4,779.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $6,150.42 | 2019-2025 | Tisseel, Artiss, Perclot |
| Abbvie INC. | $2,258.34 | 2023-2025 | |
| Allergan, INC. | $1,865.61 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,607.83 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $517.16 | 2025 | Novosorb Btm |
| Merz North America, INC. | $475.55 | 2019 | |
| Tela Bio, INC. | $337.18 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $296.04 | 2022 | |
| Innovation Technologies INC | $176.13 | 2022 | |
| Tepha INC | $152.19 | 2020 | |
| Kci USA, INC. | $127.21 | 2021-2023 | Prevena |
| Smith+Nephew, INC. | $101.15 | 2022 | |
| Mimedx Group, INC. | $21.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Mosiello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.